Europe
Denmark’s H. Lundbeck and Japan’s Otsuka Pharmaceutical announced that their brexpiprazole failed to meet its primary endpoint in two Phase III clinical trials to treat manic episodes in patients with bipolar I disorder.
The European Commission has allocated, through the H2020-EIC-SMEInst-2018-2020-Phase 2 program, a total of 1,085.659€ to the BERMES project of Aromics, the objective of which is to complete the regulatory pre-clinical stage in order to begin studies in humans of the drug NAX035 for malignant mesothelioma, an aggressive and highly resistant cancer linked to asbestos exposure.
Results Confirm and Extend 40-Week Findings that Treatment with Crysvita is Superior to Conventional Therapy
InflaRx N.V. announced that Mr. Richard Brudnick has been appointed, as interim Non-Executive Director to the Board of Directors of InflaRx N.V.
Medtronic plc (NYSE:MDT) and the Medical University of South Carolina (MUSC) today announced a five-year value-based health care partnership intended to transform and improve care for patients in South Carolina.
The thirteenth annual BIO-Europe Spring®international partnering conference meets in Vienna, Austria, March 25–27, 2019, at the Messe Wien Exhibition and Congress Center.
Recipharm announced that all fifteen of its facilities outlined in its investment plan are now fully prepared for drug serialisation and have delivered serialised batches within Europe ahead of the February 9th deadline.
Karolinska Development AB publishes its Q4 and 2018 Year-End Report with a positive quarterly and full-year result. The full report is available on the Company’s website.
MDxHealth SA announces that it has signed an exclusive distribution agreement with LifeLabs to make SelectMDx®, the Company’s non-invasive liquid biopsy prostate cancer test, available in Canada.
Doctors’ leadership in pediatric resuscitation improved most when they wore a blindfold during simulation training
PRESS RELEASES